COMMUNIQUÉS West-GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/02/2025
SOUTH SAN FRANCISCO, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on January 31, 2025 it granted stock options to purchase an aggregate of 64,587 shares of [...]
Revium Rx (RVRC) Completes Acquisition of LipoVation Ltd.
04/02/2025
Revium Rx Shifts Focus with Acquisition of LipoVation Ltd., Advancing Nanoparticle-Based Drug Development Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- February 4, 2025 – Revium Rx (formerly Revium Recovery Inc., OTC: RVRC [...]
LiveCare Inc. Announces Resolution of Investigation with the U.S. Department of Justice After Proactive Self-Disclosure
04/02/2025
Venice, Florida, Feb. 04, 2025 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTCMKTS: LVCE), today announced the resolution of an investigation by the U.S. Department of Justice of allegations related to the Anti-Kickback Statute [...]
Jushi Announces Support of Adult-Use Cannabis in Pennsylvania Governor’s Annual Budget Proposal and Address
04/02/2025
BOCA RATON, Fla., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) ( OTCQX: JUSHF ), a vertically integrated, multi-state cannabis operator, made the following statement [...]
Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering
04/02/2025
Rutherford, NJ., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
04/02/2025
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 4 février 2025 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
04/02/2025
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME) With as few as two treatments per year, Susvimo may help people with [...]
Soda Health Achieves HITRUST e1 Certification Demonstrating Foundational Cybersecurity
04/02/2025
HITRUST e1 Certification validates Soda Health is committed to foundational cybersecurity controls and information risk management. CHICAGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Soda Health a leading provider of Smart [...]
NeuroOne® Regains Compliance with Nasdaq Listing Requirements
04/02/2025
EDEN PRAIRIE, Minn., Feb. 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
Yerbae Expands Colorado Distribution Through Eagle Rock Distributing and King Soopers, Seeking to Mirror Safety Shot’s Success in Major Supermarket Chains
04/02/2025
SCOTTSDALE, Ariz., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Yerbaé Brands Corp. (TSX-V: YERB.U; OTCQX: YERBF) (“Yerbaé” or the “Company”), a plant-based functional beverage company, today announced a new distribution agreement [...]
Thought Leadership & Innovation Foundation (TLI) Initiatives Raise Awareness of Age-related Macular Degeneration (AMD) and Low Vision
04/02/2025
MCLEAN, Va., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Thought Leadership & Innovation Foundation (TLI) , a not-for-profit organization that works at the nexus of science, technology and public health, proudly joins the [...]
Milestone Scientific Expands Adoption of CompuFlo® Epidural System with Commercial Rollout at Pain Doctors Medical LLC
04/02/2025
Dr. Ilana Etelzon Integrates CompuFlo® Epidural System into Practice Following Positive Clinical Experience ROSELAND, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer [...]
Acentra Health Welcomes Distinguished Public Sector Health Leaders Calder Lynch and Jami Snyder to its Healthcare Advisory Board; Appoints Julie Boughn as New Chair
04/02/2025
Industry experts join board of seasoned advisors offering strategic counsel on healthcare trends and policy for the company and its portfolio of state, federal, and commercial clients MCLEAN, Va., Feb. 04, 2025 (GLOBE [...]
Donations doubled on World Cancer Day to support Albertans with cancer
04/02/2025
Matching gift up to $200,000 announced, benefitting cancer patients in need of financial assistance EDMONTON, Alberta, Feb. 04, 2025 (GLOBE NEWSWIRE) -- This World Cancer Day (Tuesday, February 4), the Alberta Cancer [...]
Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones
04/02/2025
Jupiter, Florida, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL ™ , a patented resveratrol-based [...]
Outlook Therapeutics® Participates in Virtual Investor “What This Means” Segment
04/02/2025
Dr. Jennifer Kissner, SVP Clinical Development, discusses the 12-week safety and efficacy results for NORSE EIGHT clinical trial Watch the “What This Means” segment here ISELIN, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- [...]
Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease
04/02/2025
ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s disease ONAPGO is a wearable subcutaneous infusion device that provides [...]
National Nonprofit SoldierStrong Announces 2024 Recipients of Annual Commitment to Service Award
04/02/2025
STAMFORD, Conn., Feb. 04, 2025 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit dedicated to helping military Veterans take their next steps forward in life after service through the donation of revolutionary [...]
SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico
04/02/2025
TEL AVIV, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders [...]

Pages